These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 10493661)

  • 1. A rheumatologist's verdict on the safety of chloroquine versus hydroxychloroquine. Liability in off-label prescribing.
    Houpt JB
    J Rheumatol; 1999 Sep; 26(9):1864-6. PubMed ID: 10493661
    [No Abstract]   [Full Text] [Related]  

  • 2. An ophthalmological view on the efficacy and safety of chloroquine versus hydroxychloroquine.
    Easterbrook M
    J Rheumatol; 1999 Sep; 26(9):1866-8. PubMed ID: 10493662
    [No Abstract]   [Full Text] [Related]  

  • 3. More thoughts about antimalarials: should one prescribe chloroquine?
    Esdaile JM
    J Rheumatol; 1999 Sep; 26(9):1868. PubMed ID: 10493663
    [No Abstract]   [Full Text] [Related]  

  • 4. Evidence for risk of cardiomyopathy with hydroxychloroquine.
    Sumpter MD; Tatro LS; Stoecker WV; Rader RK
    Lupus; 2012 Dec; 21(14):1594-6. PubMed ID: 23036986
    [No Abstract]   [Full Text] [Related]  

  • 5. Chloroquine and hydroxychloroquine - safety profile of potential COVID-19 drugs from the rheumatologist's perspective.
    Majewski D; Majewska KA; Naskręcka M; Grygiel-Górniak B
    Ann Agric Environ Med; 2021 Mar; 28(1):122-126. PubMed ID: 33775077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chloroquine/hydroxychloroquine-induced pemphigus.
    Ghaffarpour G; Jalali MH; Yaghmaii B; Mazloomi S; Soltani-Arabshahi R
    Int J Dermatol; 2006 Oct; 45(10):1261-3. PubMed ID: 17040465
    [No Abstract]   [Full Text] [Related]  

  • 7. Ophthaproblem. Chloroquine or hydroxychloroquine retinopathy.
    Liu W; Sharma S
    Can Fam Physician; 2005 May; 51(5):671, 679-80. PubMed ID: 15934269
    [No Abstract]   [Full Text] [Related]  

  • 8. Current practice in antimalarial drug prescribing in rheumatoid arthritis.
    Bellamy N; Brooks PM
    J Rheumatol; 1986 Jun; 13(3):551-5. PubMed ID: 3735276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoglycemia induced by hydroxychloroquine in a patient treated for rheumatoid arthritis.
    Unübol M; Ayhan M; Guney E
    J Clin Rheumatol; 2011 Jan; 17(1):46-7. PubMed ID: 21169846
    [No Abstract]   [Full Text] [Related]  

  • 10. Chloroquine-induced bull's eye maculopathy.
    Lai WW; Lam DS
    Hong Kong Med J; 2005 Feb; 11(1):55-7. PubMed ID: 15687518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperpigmentation of the skin due to hydroxychloroquine.
    Rood MJ; Vermeer MH; Huizinga TW
    Scand J Rheumatol; 2008; 37(2):158. PubMed ID: 18415776
    [No Abstract]   [Full Text] [Related]  

  • 12. Canadian Consensus Conference on hydroxychloroquine.
    Canadian rheumatology association
    J Rheumatol; 2000 Dec; 27(12):2919-21. PubMed ID: 11128686
    [No Abstract]   [Full Text] [Related]  

  • 13. Keratopathy with low dose chloroquine therapy.
    Cullen AP; Chou BR
    J Am Optom Assoc; 1986 May; 57(5):368-72. PubMed ID: 3711574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Missing the bull's eye.
    Gilbert ME; Savino PJ
    Surv Ophthalmol; 2007; 52(4):440-2. PubMed ID: 17574068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chloroquine-induced bull's eye maculopathy without electrophysiologic changes].
    Cursiefen C; Grunert U; Jünemann A
    Klin Monbl Augenheilkd; 1997 Jun; 210(6):400-1. PubMed ID: 9333669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxychloroquine and chloroquine: assessing the risk of retinal toxicity.
    Aylward JM
    J Am Optom Assoc; 1993 Nov; 64(11):787-97. PubMed ID: 8120333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.
    Proudman SM; Keen HI; Stamp LK; Lee AT; Goldblatt F; Ayres OC; Rischmueller M; James MJ; Hill CL; Caughey GE; Cleland LG
    Semin Arthritis Rheum; 2007 Oct; 37(2):99-111. PubMed ID: 17391739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chloroquine and hydroxychloroquine dosage in juvenile rheumatoid arthritis].
    Laaksonen AL; Koskiahde V; Juva K
    Duodecim; 1974; 90(2):125-31. PubMed ID: 4848261
    [No Abstract]   [Full Text] [Related]  

  • 19. [Occurrence of chloroquine-induced myopathy after low-dose treatment of rheumatoid arthritis for seven years].
    Haberl A; Fischer P; Pongratz D; Sieb JP
    Z Rheumatol; 2005 May; 64(4):274-6. PubMed ID: 15909088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of hydroxychloroquine sulphate in rheumatoid arthritis: a randomized, double-blind, placebo controlled clinical trial--an Indian experience.
    Das SK; Pareek A; Mathur DS; Wanchu A; Srivastava R; Agarwal GG; Chauhan RS
    Curr Med Res Opin; 2007 Sep; 23(9):2227-34. PubMed ID: 17692155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.